Cargando…

FLT3-ITD, NPM1, and DNMT3A Gene Mutations and Risk Factors in Normal Karyotype Acute Myeloid Leukemia and Myelodysplastic Syndrome Patients in Upper Northern Thailand

OBJECTIVE: Approximately 40-45% of AML and MDS patients have a cytogenetically normal karyotype (CN-AML and CN-MDS). The frequency and types of gene mutations in these cases may differ among various populations. The objective of this study was to identify frequencies and types of FLT3-ITD, NPM1, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Mevatee, Piyanan, Tantiworawit, Adisak, Traisathit, Patrinee, Puaninta, Chaniporn, Mevatee, Umnat, Angsuchawan, Sirinda, Bumroongkit, Kanokkan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5773788/
https://www.ncbi.nlm.nih.gov/pubmed/29172276
http://dx.doi.org/10.22034/APJCP.2017.18.11.3031
_version_ 1783293635430711296
author Mevatee, Piyanan
Tantiworawit, Adisak
Traisathit, Patrinee
Puaninta, Chaniporn
Mevatee, Umnat
Angsuchawan, Sirinda
Bumroongkit, Kanokkan
author_facet Mevatee, Piyanan
Tantiworawit, Adisak
Traisathit, Patrinee
Puaninta, Chaniporn
Mevatee, Umnat
Angsuchawan, Sirinda
Bumroongkit, Kanokkan
author_sort Mevatee, Piyanan
collection PubMed
description OBJECTIVE: Approximately 40-45% of AML and MDS patients have a cytogenetically normal karyotype (CN-AML and CN-MDS). The frequency and types of gene mutations in these cases may differ among various populations. The objective of this study was to identify frequencies and types of FLT3-ITD, NPM1, and DNMT3A mutations, and associations of them with clinical data and risk factors in CN-AML and CN-MDS cases in upper Northern Thailand. METHODS: Bone marrow samples of 40 CN-AML and 60 CN-MDS patients were analyzed for gene mutations by direct sequencing. In addition, data for potential risk factors were obtained for comparison. RESULTS: Frequencies of FLT3-ITD, NPM1, and DNMT3A mutations were 25.0%, 17.5%, and 10.0%, respectively in CN-AML, but all zero in CN-MDS cases. NPM1 mutations were found at a median age older than the wild type (58 vs 47 years) while DNMT3A mutations were associated with an increase in the white blood cell count. In all patients, factors for the mutations of these three genes included age ≤ 60 years, and a history of hypertension. CONCLUSION: When considering mutations in only normal karyotype patients, the frequency of FLT3-ITD, NPM1, DNMT3A mutations in CN-AML patients in upper Northern Thailand were found to occur at lower rates than in Western patients and to differ from other Asian populations including parts of Thailand. No mutations were observed in CN-MDS cases. Some types of gene mutations differed from previous studies, possibly attributable to differences in geography, lifestyle and genetic backgrounds. Links with age ≤ 60 years and history of hypertension were found. Investigation of these three genes in an intermediate risk group with a normal karyotype is useful for a better understanding of molecular leukemogenetic steps in CN-AML and CN-MDS patients and may be beneficial for planning treatment and prevention in the population of upper Northern Thailand.
format Online
Article
Text
id pubmed-5773788
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher West Asia Organization for Cancer Prevention
record_format MEDLINE/PubMed
spelling pubmed-57737882018-02-01 FLT3-ITD, NPM1, and DNMT3A Gene Mutations and Risk Factors in Normal Karyotype Acute Myeloid Leukemia and Myelodysplastic Syndrome Patients in Upper Northern Thailand Mevatee, Piyanan Tantiworawit, Adisak Traisathit, Patrinee Puaninta, Chaniporn Mevatee, Umnat Angsuchawan, Sirinda Bumroongkit, Kanokkan Asian Pac J Cancer Prev Research Article OBJECTIVE: Approximately 40-45% of AML and MDS patients have a cytogenetically normal karyotype (CN-AML and CN-MDS). The frequency and types of gene mutations in these cases may differ among various populations. The objective of this study was to identify frequencies and types of FLT3-ITD, NPM1, and DNMT3A mutations, and associations of them with clinical data and risk factors in CN-AML and CN-MDS cases in upper Northern Thailand. METHODS: Bone marrow samples of 40 CN-AML and 60 CN-MDS patients were analyzed for gene mutations by direct sequencing. In addition, data for potential risk factors were obtained for comparison. RESULTS: Frequencies of FLT3-ITD, NPM1, and DNMT3A mutations were 25.0%, 17.5%, and 10.0%, respectively in CN-AML, but all zero in CN-MDS cases. NPM1 mutations were found at a median age older than the wild type (58 vs 47 years) while DNMT3A mutations were associated with an increase in the white blood cell count. In all patients, factors for the mutations of these three genes included age ≤ 60 years, and a history of hypertension. CONCLUSION: When considering mutations in only normal karyotype patients, the frequency of FLT3-ITD, NPM1, DNMT3A mutations in CN-AML patients in upper Northern Thailand were found to occur at lower rates than in Western patients and to differ from other Asian populations including parts of Thailand. No mutations were observed in CN-MDS cases. Some types of gene mutations differed from previous studies, possibly attributable to differences in geography, lifestyle and genetic backgrounds. Links with age ≤ 60 years and history of hypertension were found. Investigation of these three genes in an intermediate risk group with a normal karyotype is useful for a better understanding of molecular leukemogenetic steps in CN-AML and CN-MDS patients and may be beneficial for planning treatment and prevention in the population of upper Northern Thailand. West Asia Organization for Cancer Prevention 2017 /pmc/articles/PMC5773788/ /pubmed/29172276 http://dx.doi.org/10.22034/APJCP.2017.18.11.3031 Text en Copyright: © Asian Pacific Journal of Cancer Prevention http://creativecommons.org/licenses/BY-SA/4.0 This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
spellingShingle Research Article
Mevatee, Piyanan
Tantiworawit, Adisak
Traisathit, Patrinee
Puaninta, Chaniporn
Mevatee, Umnat
Angsuchawan, Sirinda
Bumroongkit, Kanokkan
FLT3-ITD, NPM1, and DNMT3A Gene Mutations and Risk Factors in Normal Karyotype Acute Myeloid Leukemia and Myelodysplastic Syndrome Patients in Upper Northern Thailand
title FLT3-ITD, NPM1, and DNMT3A Gene Mutations and Risk Factors in Normal Karyotype Acute Myeloid Leukemia and Myelodysplastic Syndrome Patients in Upper Northern Thailand
title_full FLT3-ITD, NPM1, and DNMT3A Gene Mutations and Risk Factors in Normal Karyotype Acute Myeloid Leukemia and Myelodysplastic Syndrome Patients in Upper Northern Thailand
title_fullStr FLT3-ITD, NPM1, and DNMT3A Gene Mutations and Risk Factors in Normal Karyotype Acute Myeloid Leukemia and Myelodysplastic Syndrome Patients in Upper Northern Thailand
title_full_unstemmed FLT3-ITD, NPM1, and DNMT3A Gene Mutations and Risk Factors in Normal Karyotype Acute Myeloid Leukemia and Myelodysplastic Syndrome Patients in Upper Northern Thailand
title_short FLT3-ITD, NPM1, and DNMT3A Gene Mutations and Risk Factors in Normal Karyotype Acute Myeloid Leukemia and Myelodysplastic Syndrome Patients in Upper Northern Thailand
title_sort flt3-itd, npm1, and dnmt3a gene mutations and risk factors in normal karyotype acute myeloid leukemia and myelodysplastic syndrome patients in upper northern thailand
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5773788/
https://www.ncbi.nlm.nih.gov/pubmed/29172276
http://dx.doi.org/10.22034/APJCP.2017.18.11.3031
work_keys_str_mv AT mevateepiyanan flt3itdnpm1anddnmt3agenemutationsandriskfactorsinnormalkaryotypeacutemyeloidleukemiaandmyelodysplasticsyndromepatientsinuppernorthernthailand
AT tantiworawitadisak flt3itdnpm1anddnmt3agenemutationsandriskfactorsinnormalkaryotypeacutemyeloidleukemiaandmyelodysplasticsyndromepatientsinuppernorthernthailand
AT traisathitpatrinee flt3itdnpm1anddnmt3agenemutationsandriskfactorsinnormalkaryotypeacutemyeloidleukemiaandmyelodysplasticsyndromepatientsinuppernorthernthailand
AT puanintachaniporn flt3itdnpm1anddnmt3agenemutationsandriskfactorsinnormalkaryotypeacutemyeloidleukemiaandmyelodysplasticsyndromepatientsinuppernorthernthailand
AT mevateeumnat flt3itdnpm1anddnmt3agenemutationsandriskfactorsinnormalkaryotypeacutemyeloidleukemiaandmyelodysplasticsyndromepatientsinuppernorthernthailand
AT angsuchawansirinda flt3itdnpm1anddnmt3agenemutationsandriskfactorsinnormalkaryotypeacutemyeloidleukemiaandmyelodysplasticsyndromepatientsinuppernorthernthailand
AT bumroongkitkanokkan flt3itdnpm1anddnmt3agenemutationsandriskfactorsinnormalkaryotypeacutemyeloidleukemiaandmyelodysplasticsyndromepatientsinuppernorthernthailand